CPT Code 11642: Reimbursement, modifiers, and documentation

Key Takeaways

CPT Code 11642 covers excision of a malignant lesion including margins on the face, ears, eyelids, nose, or lips with an excised diameter of 1.1 to 2.0 cm.

The 2026 Medicare non-facility national average reimbursement is approximately $265-$270. Facility rates are lower, around $150-$160, due to reduced practice expense RVU.

A pathology report confirming malignancy is required for Medicare coverage of CPT 11642 and is a common audit finding when missing.

Pabau’s claims management software supports accurate coding for the 11600-series with a centralized claims dashboard and documentation templates for dermatology practices.

CPT Code 11642 is the mid-tier facial excision code, covering excision of a malignant lesion including margins on the face, ears, eyelids, nose, or lips where the total excised diameter falls between 1.1 and 2.0 cm.

It sits within the 11640-11646 family, where the correct code depends on anatomic site and excised diameter, and a wrong measurement or a mismatched diagnosis code is where many denials on these claims start.

This guide covers what dermatology and plastic surgery coders need for CPT 11642: the clinical description, RVU and reimbursement data, related codes in the 11600-series, ICD-10 pairings, modifiers, and the documentation required for a clean claim.

CPT Code 11642: Definition and clinical description

CPT Code 11642 covers the excision of a malignant lesion including margins located on the face, ears, eyelids, nose, or lips, where the excised diameter measures between 1.1 and 2.0 centimeters. The code belongs to the Excision-Malignant Lesions Procedures on the Skin section of the AMA’s CPT code set, maintained by the AMA CPT Editorial Panel.

One critical measurement rule catches many coders off guard. The excised diameter includes the lesion itself plus the narrowest margin taken around it, not the lesion alone.

If a physician removes a 0.8 cm basal cell carcinoma with 0.2 cm margins on each side, the reported diameter is 1.2 cm, placing the case squarely within CPT 11642 rather than its smaller-diameter sibling, CPT 11641. Getting this wrong in either direction risks a claim denial or an upcoding audit flag.

This code applies to procedures performed by dermatologists, plastic surgeons, and other qualified clinicians removing malignant neoplasms from cosmetically and functionally sensitive facial anatomy. The full-thickness excision technique, confirmation of clear margins, and post-excision wound closure all fall within the scope of this code.

Simple repair (linear wound closure) is included in CPT 11642 and cannot be billed separately. Complex repair, flap closure, or skin grafting may be billed with an appropriate modifier when a separately identifiable service is performed.

CPT 11642 in the 11600-series: Choosing the right code

Malignant lesion excision billing guidelines for the 11600-series organize codes by two variables: anatomic site and excised diameter. Picking the wrong code on either axis triggers a denial. The table below maps the full family so coders can verify CPT 11642 sits in the correct slot.

The facial anatomy designation (11640-11646) consistently reimburses at higher rates than the trunk/extremity counterparts (11600-11606) because facial excisions carry greater operative complexity and risk. A lesion removed from the nose tip or eyelid margin demands tighter margin control and more meticulous closure.

Practices billing 11602 for a facial lesion when 11642 applies are leaving revenue on the table and creating a documentation mismatch. For guidance on software that integrates with plastic surgery EMR software workflows for these procedures, resources are available on the Pabau blog.

Medicare reimbursement rates for CPT 11642

The Medicare Physician Fee Schedule (MPFS) sets national averages for CPT 11642 that vary by site of service. According to fee schedule data published through the CMS Physician Fee Schedule, the non-facility (office) national average for CPT 11642 is approximately $265-$270.

The facility rate (hospital outpatient or ambulatory surgery center) is approximately $150-$160, lower due to reduced practice expense reimbursement in those settings.

Geographic Practice Cost Index (GPCI) adjustments apply to all MPFS rates. A practice in Manhattan will see higher reimbursement than one in rural Mississippi.

Clinicians should verify rates for their specific Medicare Administrative Contractor (MAC) locality using the CMS lookup tool rather than relying on national averages when forecasting revenue. Private payer rates for CPT 11642 typically exceed Medicare by 10-40%, though this varies by contract and carrier.

RVU breakdown for CPT Code 11642

Understanding the RVU components for CPT 11642 explains how Medicare translates relative value into payment. The FastRVU 2026 lookup tool provides current Work, Practice Expense, and Malpractice RVU values for CPT 11642. The total payment is calculated by multiplying total RVUs by the 2026 Medicare conversion factor and applying GPCI adjustments.

RVU values update annually with the CMS MPFS final rule, typically published in November for the following calendar year. The figures above reflect the 2026 CMS Physician Fee Schedule. Confirm current values against the official CMS lookup tool before use in financial projections.

Facility vs non-facility billing for CPT 11642

The site-of-service distinction materially affects reimbursement for CPT 11642. When the procedure is performed in the physician’s office (non-facility), Medicare reimburses for both physician work and the practice’s overhead (equipment, supplies, staff).

When performed in a hospital outpatient department or ASC (facility), the facility separately bills for overhead, so Medicare pays the physician only the lower facility rate.

For a dermatology practice with its own procedure room, performing CPT 11642 in the office setting optimizes reimbursement. Moving procedures to a hospital setting can reduce physician payment by 25-35% compared to the non-facility rate.

Practices should factor this into their site-of-service decisions, particularly for high-volume excision workflows. Using compliance management tools that flag site-of-service mismatches helps prevent inadvertent billing errors.

Common modifiers for CPT 11642

Modifier selection for CPT 11642 is where clean claims most often go wrong. Applying the wrong modifier (or none at all) when one is required leads to bundling denials, payment reductions, or payer audits.

Modifier guidance is payer-specific. Medicare NCCI edits govern bundling for CPT 11642. Commercial payers may follow different bundling logic.

Modifier -59 should only be applied when clinical documentation clearly supports a distinct service, not as a blanket denial-avoidance tool. The OIG Office of Inspector General has flagged inappropriate use of modifier -59 as an audit risk area across dermatology and surgical subspecialties.

ICD-10-CM codes that support CPT 11642

Every CPT 11642 claim requires a linked ICD-10-CM diagnosis code that confirms the excised lesion was malignant and matches the documented anatomic site. Medicare’s Local Coverage Determination (LCD) for malignant skin lesion excision explicitly requires diagnosis-to-site alignment.

Per the CMS ICD-10 codes page, the C44 series covers malignant neoplasms of skin by anatomic site.

The ICD-10-CM diagnosis must reflect the anatomic site stated in the operative note. A claim pairing C44.21x (ear skin carcinoma) with a surgical note documenting a nasal lesion will fail payer crosswalk edits.

Confirm pathology before billing malignant codes: in-situ codes (D03/D04 series) may not satisfy Medicare’s medical necessity criteria for the 11642 reimbursement level at all payers, so verify LCD coverage before submitting.

For broader context on how HIPAA-compliant billing workflows support accurate diagnosis code assignment, the Pabau blog covers key compliance considerations.

Documentation requirements for CPT 11642

Missing or incomplete documentation is the primary reason CPT 11642 claims are denied on audit. The CMS coverage database LCD for excision of malignant skin lesions outlines specific documentation requirements. Every element below must appear in the medical record before the claim is submitted.

• Lesion size before excision: Document the lesion diameter in centimeters in the pre-operative assessment or procedure note.
• Margin width: Record the planned and achieved margin width. The operative note should state the narrowest margin taken to confirm the total excised diameter calculation.
• Anatomic location: Specify the exact site (e.g. left nasal ala, right earlobe, upper lip vermillion border) to support diagnosis-code alignment.
• Total excised diameter: Calculate and record lesion diameter plus narrowest margin. This figure determines which CPT code applies.
• Pathology report: A pathology report confirming malignancy is required for Medicare coverage. Submitting a claim for 11642 before pathology results are returned is a common audit finding. Bill after confirmation, not at the time of procedure.
• Medical necessity statement: The clinical note should document why surgical excision was indicated, referencing the malignant diagnosis and any prior treatment failure where relevant.
• Closure technique: Note whether simple repair was performed (included in 11642) or a more complex closure was used (separately billable with documentation).

Using digital clinical forms configured to capture lesion size, margin, and site at the point of care reduces the risk of missing documentation that triggers retrospective claim denials.

Practices using standardized structured client records for dermatology procedures report fewer documentation-related denials compared to those relying on free-text operative notes. The goal is capturing every required data point before the patient leaves the procedure room, not at billing time.

How Pabau supports dermatology billing workflows for CPT 11642

Billing accuracy for malignant excision codes depends on connecting clinical documentation to the claim at every step. A missed lesion measurement in the operative note can mean billing 11641 instead of 11642, a difference of $30-60 per procedure that compounds quickly across a high-volume dermatology practice.

Pabau’s claims management software is built for exactly this workflow. A centralized claims dashboard tracks every CPT 11642 claim through pending, submitted, processing, paid, or error status, with claims and billing handled directly within the platform.

Background field-validation checks confirm details like membership numbers and authorization codes before a claim can be sent. Documentation templates can be configured to capture lesion diameter, margin width, anatomic site, and closure technique as discrete structured fields, not buried in free-text notes.

Practices operating dermatology EMR software integrated with billing find that automated claim scrubbing catches diagnosis-to-site mismatches, for example an ear ICD-10 code paired with a facial operative note, before the claim leaves the practice. This reduces the rate of first-pass denials and the administrative burden of resubmission.

For skin clinic software users, the same automated workflows apply across the full 11600-series, not just CPT 11642. Practices using automated billing workflows for skin procedures can also link clinical documentation directly to outgoing claims, reducing the manual reconciliation work where most denials originate.

Reduce claim denials on malignant excision codes

Pabau's claims management software supports accurate CPT 11642 billing with a centralized claims dashboard, real-time status tracking, and configurable documentation templates for dermatology and plastic surgery practices.

Book a demo

Conclusion

CPT Code 11642 is a precision code where documentation errors, site-code mismatches, and missed modifier opportunities translate directly into lost revenue or audit exposure.

The most consistent problems in dermatology and plastic surgery billing for this code come down to three things: calculating the excised diameter incorrectly, submitting before pathology is confirmed, and applying modifier -59 without adequate documentation to support it.

Pabau’s clinical documentation workflows give dermatology and plastic surgery practices the structure to capture every required data element at the point of care, so the claim reflects the procedure performed in the room.

To see how this works for your practice, book a demo with the Pabau team.

Continue your research

Billing Mohs surgery instead? CPT 17314 breaks down modifiers and Medicare rates for micrographic excision billing.

Managing dermatology billing across locations? Multi-location management in Pabau centralizes scheduling, staffing, pricing, inventory, and reporting across every site, giving multi-site practices one consistent view instead of separate location systems.

Coding a different anesthesia case? CPT 00912 covers TURBT anesthesia billing and reimbursement.

Need a musculoskeletal diagnosis pairing? ICD-10 M61.9 covers coding guidance for calcification and ossification of muscle.

Frequently asked questions